Nectin Therapeutics
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Bridge Plaza North Central Rd Ste 675,...Phone Number
(201) 218-1774Website
www.nectintx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nectin Therapeutics
Nectin Therapeutics is a biotechnology company aiming to transform the lives of cancer patients by leveraging its unique insights into the nectin pathway to develop the next generation of immuno-oncology (IO) therapies. The company's differentiated therapies have the potential to achieve new standards for efficacy and patient response across a number of difficult-to-treat cancers. Nectin's technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies and antibody-drug-conjugates. It has a world-class scientific and management team with deep experience in oncology drug development and a successful track record in building biotechnology companies and developing innovative therapies. Nectin Therapeutics is a venture-backed, privately held company, funded by aMoon Fund, IBF, Peregrine Ventures, Integra Holdings and Cancer Focus Fund.Explore more
Nectin Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nectin Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Nectin Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Nectin Therapeutics had a recent Job posting/layoffs
Nectin Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nectin Therapeutics has new funding data
Check out if Nectin Therapeutics is spiking on competitors!
Earning: See what the market has to say on Nectin Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nectin Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nectin Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Nectin Therapeutics
Find more new buyers
Compare Similar Companies to Nectin Therapeutics
Compare insights from companies similar to Nectin Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nectin Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nectin Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nectin Therapeutics.
Nectin Therapeutics financials insights
Gather financial insights about Nectin Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$25M
Nectin Therapeutics Tech Stack
A closer look at the technologies used by Nectin Therapeutics
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Partnership, Research & Development, Product Management, Intellectual Property, Legal Affairs, Medical Research
Project
Product Development, Research & Development
Funding
Funding
Nectin Therapeutics News & Media
GIBF invests $10 Million in Nectin Therapeutics to Advance Novel Pipeline of First-in-Class Immunotherapies and Antibody Drug Conjugates
Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel, May 6, 2024 /PRNewswire/ -- Guangzhou-Israel Biotechnology Fund (GIBF) announced today that it has invested $10...Nectin Therapeutics Advances Ongoing Clinical Trial and Expands Sites to Israel
The clinical trial for NTX1088 has progressed to include a new combination arm with KEYTRUDA® and expanded to 5 global sites, including 2 Israeli sites JERUSALEM, Dec. 26, 2023 /PRNewswire/ -- Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted...Myeloma Investment Fund Invests in Nectin Therapeutics
JERUSALEM & NORWALK, Conn.–(BUSINESS WIRE)–Nectin Therapeutics, a biotechnology company developing novel targeted immunotherapies to address tumor immune resistance, and the Myeloma... Read More The post Myeloma Investment Fund Invests in Nectin Therapeutics appeared first on citybiz.Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma
JERUSALEM & NORWALK, Conn.--(BUSINESS WIRE)--The Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nectin Therapeutics
Sign Up For FreeTo access detailed company insights
Nectin Therapeutics is a biotechnology company aiming to transform the lives of cancer patients by leveraging its unique insights into the nectin pathway to develop the next generation of immuno-oncology (IO) therapies. The company's differentiated therapies have the potential to achieve new standards for efficacy and patient response across a numb... Read More
